Key Takeaways
- • JLL Partners, a New York-based middle-market private equity firm, completed its acquisition of Life Couriers, a Munich-headquartered global healthcare logistics provider, as of August 17, 2026.
- • Edward DeMartini, a healthcare logistics executive with more than 20 years of industry experience, has been appointed Chief Executive Officer, replacing founder Stefan Glebke, who transitions to strategic advisor role to ensure continuity.
- • Life Couriers operates across six core business segments—radiopharma, life sciences, stem cell onboard, direct-to-patient, pharma freight, and emergency logistics—with geographic presence spanning the U.S., Europe, Central America, and Asia.
- • The acquisition positions Life Couriers to accelerate geographic expansion and capitalize on rising demand for radiopharmaceutical transport and direct-to-patient healthcare logistics solutions, supported by JLL's operational expertise and financial backing.
- • JLL Partners brings specialized healthcare, industrials, and business services sector focus to the deal, with clear intent to scale the platform through organic growth and potential add-on acquisitions in the outsourced healthcare logistics market.
Summary
JLL Partners, a New York-based private equity firm specializing in middle-market healthcare, industrials, and business services investments, has completed its acquisition of Life Couriers, a Munich-headquartered provider of time-critical healthcare and life science logistics. The transaction closed on August 17, 2026, marking a significant consolidation event in the specialized pharmaceutical and healthcare logistics sector. The previous owner, AUCTUS Capital, divested the asset as part of portfolio rebalancing activity flagged in October 2025.
The leadership transition reflects a strategic shift toward aggressive growth and geographic expansion. Edward DeMartini, a seasoned transportation and specialty healthcare logistics executive with over two decades of industry experience, assumes the CEO role. Stefan Glebke, Life Couriers' founder and outgoing CEO, remains embedded as a strategic advisor to the board, ensuring institutional knowledge preservation and smooth operational transition—a common governance practice in add-on acquisition scenarios where founder knowledge retention is material to customer relationships and operational continuity.
Life Couriers operates a diversified healthcare logistics platform across six business segments: radiopharma logistics, life sciences, stem cell onboard services, direct-to-patient delivery, pharma freight, and emergency logistics. The company maintains operational hubs throughout North America, Europe, Central America, and Asia, positioning it to serve multinational pharmaceutical manufacturers and specialized healthcare providers. The business addresses secular tailwinds in outsourced healthcare logistics, particularly rising demand for radiopharmaceutical distribution and time-sensitive direct-to-patient medical supply chains—segments characterized by high barriers to entry, regulatory complexity, and predictable recurring revenue.
JLL Partners' investment thesis emphasizes operational scaling and geographic expansion. The firm brings proven healthcare sector expertise and financial resources to support both organic growth initiatives and bolt-on acquisitions that could expand Life Couriers' service capabilities or regional footprint. The combination of founder-level operational continuity with experienced external leadership positions the platform to pursue disciplined growth in an increasingly consolidated market where specialized logistics capabilities command premium valuations.
The leadership transition reflects a strategic shift toward aggressive growth and geographic expansion. Edward DeMartini, a seasoned transportation and specialty healthcare logistics executive with over two decades of industry experience, assumes the CEO role. Stefan Glebke, Life Couriers' founder and outgoing CEO, remains embedded as a strategic advisor to the board, ensuring institutional knowledge preservation and smooth operational transition—a common governance practice in add-on acquisition scenarios where founder knowledge retention is material to customer relationships and operational continuity.
Life Couriers operates a diversified healthcare logistics platform across six business segments: radiopharma logistics, life sciences, stem cell onboard services, direct-to-patient delivery, pharma freight, and emergency logistics. The company maintains operational hubs throughout North America, Europe, Central America, and Asia, positioning it to serve multinational pharmaceutical manufacturers and specialized healthcare providers. The business addresses secular tailwinds in outsourced healthcare logistics, particularly rising demand for radiopharmaceutical distribution and time-sensitive direct-to-patient medical supply chains—segments characterized by high barriers to entry, regulatory complexity, and predictable recurring revenue.
JLL Partners' investment thesis emphasizes operational scaling and geographic expansion. The firm brings proven healthcare sector expertise and financial resources to support both organic growth initiatives and bolt-on acquisitions that could expand Life Couriers' service capabilities or regional footprint. The combination of founder-level operational continuity with experienced external leadership positions the platform to pursue disciplined growth in an increasingly consolidated market where specialized logistics capabilities command premium valuations.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.